Clinical Trials Logo
  1. Home
  2. Hereditary Ataxia
  3. NCT05160883
  4. Details
NCT05160883 Clinical Trial

Neuroimaging Changes in Hereditary Ataxia

Hereditary Ataxia Clinical Trial

Official title:
Neuroimaging Changes in Hereditary Ataxia

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05160883
Other study ID # Wulab-MRI in HA
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 30, 2021
Est. completion date December 25, 2025

Study information
Verified date November 2021
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aim to investigate the neuroimaging changes of hereditary ataxia patients, especially in the SCA3 patients in preclinical or mild stage.

Recruitment information / eligibility
Status Recruiting
Enrollment 500
Est. completion date December 25, 2025
Est. primary completion date December 25, 2025
Accepts healthy volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - genetically diagnosed as Spinocerebellar ataxia Exclusion Criteria: - deny to follow-up

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
China Second Affiliated Hospital,Zhejiang University School of Medicine Hangzhou Zhejiang

Sponsors (1)
Lead Sponsor Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary neuroimaging information neuroimaging information approached by MRI, including 3D-T1, T2, DTI, rsfMRI, SWI, ASL were collected from 2021 to 2025
See also
  Status Clinical Trial Phase
Completed NCT00004306 - Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10) N/A
Completed NCT04750850 - Core Stability Exercises and Hereditary Ataxia N/A
Active, not recruiting NCT06152133 - Telerehabilitation, Core Stability Exercises and Hereditary Ataxia (TRCore-ataxia) N/A
Recruiting NCT05160870 - Genotype-phenotype Correlation and Pathogenic Mechanism in Hereditary Ataxia
Completed NCT00202397 - Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia Phase 2
Recruiting NCT01360164 - Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia Phase 1/Phase 2